 Joanne Cole
Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 3 | 2021 | 103 | 1.270 |
Why?
| | Genome-Wide Association Study | 15 | 2022 | 1407 | 1.130 |
Why?
| | Diabetes Mellitus, Type 2 | 11 | 2023 | 2584 | 1.050 |
Why?
| | Face | 3 | 2017 | 174 | 1.010 |
Why?
| | Diabetic Nephropathies | 5 | 2022 | 318 | 0.650 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 374 | 0.620 |
Why?
| | Maxillofacial Development | 2 | 2016 | 20 | 0.620 |
Why?
| | Diabetes Complications | 1 | 2020 | 223 | 0.560 |
Why?
| | Genetic Association Studies | 1 | 2020 | 373 | 0.550 |
Why?
| | Facial Bones | 1 | 2017 | 28 | 0.530 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2016 | 8 | 0.500 |
Why?
| | Malnutrition | 1 | 2017 | 86 | 0.490 |
Why?
| | Quantitative Trait, Heritable | 1 | 2016 | 118 | 0.470 |
Why?
| | Genomics | 1 | 2020 | 836 | 0.420 |
Why?
| | Diet | 2 | 2021 | 1275 | 0.420 |
Why?
| | Genetic Predisposition to Disease | 8 | 2023 | 2365 | 0.420 |
Why?
| | Feeding Behavior | 1 | 2020 | 685 | 0.410 |
Why?
| | Genetic Loci | 4 | 2022 | 261 | 0.390 |
Why?
| | Polymorphism, Single Nucleotide | 8 | 2022 | 2147 | 0.390 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2171 | 0.380 |
Why?
| | Genetic Variation | 2 | 2021 | 984 | 0.370 |
Why?
| | Child Development | 1 | 2017 | 484 | 0.370 |
Why?
| | Carrier Proteins | 1 | 2016 | 737 | 0.360 |
Why?
| | United Kingdom | 2 | 2021 | 338 | 0.300 |
Why?
| | Genotype | 5 | 2022 | 1835 | 0.300 |
Why?
| | Phenotype | 6 | 2022 | 3164 | 0.300 |
Why?
| | Tanzania | 3 | 2017 | 73 | 0.290 |
Why?
| | Obesity | 6 | 2026 | 3082 | 0.270 |
Why?
| | Body Mass Index | 3 | 2026 | 2438 | 0.240 |
Why?
| | Multifactorial Inheritance | 2 | 2022 | 203 | 0.200 |
Why?
| | Mendelian Randomization Analysis | 2 | 2021 | 55 | 0.200 |
Why?
| | Dyslipidemias | 2 | 2022 | 182 | 0.190 |
Why?
| | Adipose Tissue, Beige | 1 | 2022 | 2 | 0.190 |
Why?
| | Humans | 26 | 2026 | 144957 | 0.180 |
Why?
| | Genes, Recessive | 1 | 2022 | 78 | 0.180 |
Why?
| | Overweight | 1 | 2026 | 609 | 0.170 |
Why?
| | Hyperuricemia | 1 | 2021 | 47 | 0.170 |
Why?
| | Gene-Environment Interaction | 1 | 2022 | 180 | 0.170 |
Why?
| | Gout | 1 | 2021 | 35 | 0.160 |
Why?
| | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2020 | 11 | 0.160 |
Why?
| | Weight Loss | 1 | 2026 | 837 | 0.160 |
Why?
| | Disease | 1 | 2021 | 98 | 0.160 |
Why?
| | Loss of Function Mutation | 1 | 2020 | 46 | 0.160 |
Why?
| | Metabolome | 2 | 2022 | 384 | 0.160 |
Why?
| | Inheritance Patterns | 1 | 2020 | 44 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 170 | 0.160 |
Why?
| | Receptors, Odorant | 1 | 2020 | 32 | 0.150 |
Why?
| | Glomerular Basement Membrane | 1 | 2019 | 8 | 0.150 |
Why?
| | Collagen Type IV | 1 | 2019 | 28 | 0.150 |
Why?
| | Principal Component Analysis | 1 | 2020 | 198 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2021 | 348 | 0.150 |
Why?
| | Diabetic Neuropathies | 1 | 2020 | 100 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 422 | 0.140 |
Why?
| | Multigene Family | 1 | 2018 | 204 | 0.130 |
Why?
| | Growth | 1 | 2017 | 49 | 0.130 |
Why?
| | Diabetic Retinopathy | 1 | 2020 | 208 | 0.130 |
Why?
| | Cross-Sectional Studies | 5 | 2023 | 5872 | 0.130 |
Why?
| | Eating | 1 | 2020 | 392 | 0.130 |
Why?
| | Body Size | 1 | 2017 | 95 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 2 | 2017 | 583 | 0.130 |
Why?
| | Autoantigens | 1 | 2019 | 429 | 0.120 |
Why?
| | Biomarkers | 3 | 2022 | 4275 | 0.120 |
Why?
| | Female | 10 | 2026 | 78376 | 0.120 |
Why?
| | Anthropometry | 1 | 2016 | 200 | 0.120 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2022 | 3890 | 0.120 |
Why?
| | Morphogenesis | 1 | 2016 | 173 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 2022 | 1500 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 741 | 0.110 |
Why?
| | Adolescent | 4 | 2017 | 22453 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 653 | 0.100 |
Why?
| | Transcription Factors | 1 | 2022 | 1742 | 0.100 |
Why?
| | Risk Factors | 4 | 2023 | 10792 | 0.100 |
Why?
| | Child, Preschool | 3 | 2017 | 11799 | 0.100 |
Why?
| | Male | 9 | 2026 | 72406 | 0.100 |
Why?
| | Vitiligo | 1 | 2012 | 42 | 0.090 |
Why?
| | Young Adult | 3 | 2017 | 14126 | 0.090 |
Why?
| | Mutation | 2 | 2022 | 4099 | 0.090 |
Why?
| | Stroke | 1 | 2021 | 1258 | 0.090 |
Why?
| | Prospective Studies | 2 | 2021 | 7997 | 0.090 |
Why?
| | Gene Frequency | 2 | 2022 | 481 | 0.080 |
Why?
| | Causality | 2 | 2021 | 126 | 0.080 |
Why?
| | Aging | 1 | 2021 | 1966 | 0.080 |
Why?
| | Adult | 6 | 2026 | 40506 | 0.080 |
Why?
| | Cluster Analysis | 2 | 2022 | 521 | 0.070 |
Why?
| | Haplotypes | 2 | 2021 | 490 | 0.070 |
Why?
| | Child | 3 | 2017 | 22657 | 0.070 |
Why?
| | Bayes Theorem | 2 | 2022 | 433 | 0.070 |
Why?
| | Middle Aged | 4 | 2026 | 35928 | 0.070 |
Why?
| | Metabolomics | 2 | 2026 | 727 | 0.070 |
Why?
| | DNA Methylation | 2 | 2022 | 683 | 0.060 |
Why?
| | Mitoguazone | 1 | 2023 | 1 | 0.050 |
Why?
| | Mice | 2 | 2022 | 18365 | 0.050 |
Why?
| | Adipocytes, Beige | 1 | 2022 | 1 | 0.050 |
Why?
| | Ubiquitin-Protein Ligase Complexes | 1 | 2022 | 8 | 0.050 |
Why?
| | Cullin Proteins | 1 | 2022 | 13 | 0.050 |
Why?
| | CpG Islands | 1 | 2022 | 165 | 0.050 |
Why?
| | Thermogenesis | 1 | 2022 | 45 | 0.050 |
Why?
| | Adipose Tissue, Brown | 1 | 2022 | 60 | 0.040 |
Why?
| | Ubiquitination | 1 | 2022 | 118 | 0.040 |
Why?
| | Insulin Resistance | 2 | 2022 | 1241 | 0.040 |
Why?
| | Protein Stability | 1 | 2022 | 178 | 0.040 |
Why?
| | Homozygote | 1 | 2022 | 199 | 0.040 |
Why?
| | Penetrance | 1 | 2021 | 30 | 0.040 |
Why?
| | Biological Variation, Population | 1 | 2021 | 20 | 0.040 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2021 | 16 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2022 | 142 | 0.040 |
Why?
| | Gout Suppressants | 1 | 2021 | 20 | 0.040 |
Why?
| | Europe | 1 | 2022 | 412 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 36 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 174 | 0.040 |
Why?
| | Exome | 1 | 2021 | 227 | 0.040 |
Why?
| | Cholesterol, LDL | 1 | 2022 | 358 | 0.040 |
Why?
| | Uric Acid | 1 | 2021 | 166 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 548 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 521 | 0.040 |
Why?
| | Pedigree | 1 | 2021 | 514 | 0.040 |
Why?
| | Embryonic Stem Cells | 1 | 2020 | 130 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 315 | 0.040 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2022 | 460 | 0.040 |
Why?
| | Founder Effect | 1 | 2018 | 13 | 0.040 |
Why?
| | Alleles | 1 | 2022 | 881 | 0.040 |
Why?
| | Longevity | 1 | 2020 | 173 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 1327 | 0.030 |
Why?
| | Animals | 2 | 2022 | 38109 | 0.030 |
Why?
| | Cohort Studies | 2 | 2019 | 5965 | 0.030 |
Why?
| | Precision Medicine | 1 | 2022 | 458 | 0.030 |
Why?
| | Lymphocytes | 1 | 2020 | 382 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2026 | 771 | 0.030 |
Why?
| | Anthropology, Physical | 1 | 2017 | 24 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 685 | 0.030 |
Why?
| | Genetic Markers | 1 | 2018 | 331 | 0.030 |
Why?
| | Biometry | 1 | 2017 | 68 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 249 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2836 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1464 | 0.030 |
Why?
| | Sex Factors | 1 | 2022 | 2114 | 0.030 |
Why?
| | Myocytes, Cardiac | 1 | 2020 | 556 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 681 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2882 | 0.030 |
Why?
| | Kidney | 1 | 2022 | 1496 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2020 | 600 | 0.020 |
Why?
| | Biological Evolution | 1 | 2017 | 488 | 0.020 |
Why?
| | Age Factors | 1 | 2021 | 3335 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2925 | 0.020 |
Why?
| | Eye Color | 1 | 2012 | 3 | 0.020 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 2012 | 50 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3676 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1839 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8279 | 0.020 |
Why?
| | Insulin | 1 | 2018 | 2507 | 0.020 |
Why?
| | Aged | 1 | 2020 | 25947 | 0.010 |
Why?
| | United States | 1 | 2017 | 15988 | 0.010 |
Why?
|
|
Cole's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|